Regulation of Human Interleukin 8 Gene Expression and Binding of Several Other Members of the Intercrine Family to Receptors for Interleukin-8

  • Naofumi Mukaida
  • Atsushi Hishinuma
  • Claus O. C. Zachariae
  • Joost J. Oppenheim
  • Kouji Matsushima
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 305)


Recruitment of leukocytes into tissues presumeably involves the local release of leukocyte activating and chemotactic mediators in response to injury-induced inflammatory reactions. We have recently purified major neutrophil, monocyte, and lymphocyte chemotactic factors to homogeneity from the conditioned media of human PBMC or monocytic cell line stimulated with mitogens and have shown that these chemotactic factors are structurally distinct from known cytokines, including IL-1 or TNF (1,2,3). Neutrophil chemotactic factor was structurally identical to T lymphocyte chemotactic factor and has been renamed IL-8 (3). IL-8 is distinct from the monocyte chemotactic and activating factor (MCAF) (2). cDNA cloning of IL-8 has been performed and the cDNA encodes a 99 amino acid precursor form of IL-8 (4). There is a typical signal peptide at the amino terminal end of the IL-8 precursor molecule and the mature processed soluble extracellular form of IL-8 consists of 72 amino acids. IL-8 shows considerable amino acid sequence homology to several human cytokines, such as β-thromboglobulin, platelet factor 4, gamma-IP 10 and GRO/MGSA. For ease of communication we will identify these cytokines as members of the intercrine family in this article. Such a generic term may provide useful in providing a name for members of this cytokine family based on their chromosomal location when they are precisely determined over the next few years. For example, cytokines such as IL-8 that are located on chromosome 4 can therefore be assigned a number in the intercrine α subfamily, whereas MCAF and the others on chromosome 17 can be assigned a number in the intercrine β subfamily.


Chemotactic Factor Chemotactic Cytokine Human PBMC Neutrophil Chemotactic Factor Octamer Motif 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yoshimura, T., K. Matsushima, S. Tanaka, E.A. Robinson, E. Appella, J.J. Oppenheim, and E.J. Leonard. 1987. Purification of human monocyte-derived neutrophil chemotactic factor that shares sequence homology with other host defense cytokines. Proc. Natl. Acad. Sci. USA 84: 9233–9237.PubMedCrossRefGoogle Scholar
  2. 2.
    Matsushima, K., C.G. Larsen, G.C. Dubois, and J.J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169: 1485–1490.PubMedCrossRefGoogle Scholar
  3. 3.
    Larsen, C.G., A.O. Anderson, E. Appella, J.J. Oppenheim, and K. Matsushima. 1989. Identity of chemotactic cytokine for T-lymphocytes with neutrophil activating protein (NAP-1): A candidate interleukin 8. Science 243: 1464–1466.PubMedCrossRefGoogle Scholar
  4. 4.
    Matsushima, K., K. Morishita, T. Yoshimura, S. Lavu, Y. Kobayashi, W. Lew, E. Appella, H.F. Kung, E.J. Leonard, and J.J. Oppenheim. 1988. Molecular cloning of a human monocyte derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167: 1883–1893.PubMedCrossRefGoogle Scholar
  5. 5.
    Clore, G.M., E. Appella, M. Yamada, K. Matsushima, and A.M. Gronenborn. 1990. The threedimensional structure of interleukin 8 in solution. Biochemistry 29: 1689–1696.PubMedCrossRefGoogle Scholar
  6. 6.
    Furutani, Y., H. Nomura, M. Notake, Y. Oyamada, T. Fukui, M. Yamada, C.G. Larsen, J.J. Oppenheim, and K. Matsushima 1989. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. Biophys. Res. Commun. 159: 249–255.PubMedCrossRefGoogle Scholar
  7. 7.
    Zachariae, C.O.C., A.O. Anderson, H.L. Thompson, E. Appella, A. Mantovani, J.J. Oppenheim, and K. Matsushima. 1990. Properties of monocyte chemotactic and activating factor (MCAF) purified from human fibrosarcoma cell line. J. Exp. Med. 171: 2177–2182.PubMedCrossRefGoogle Scholar
  8. 8.
    Yoshimura, T., K. Matsushima, J.J. Oppenheim, and E.J. Leonard. 1987. Neutrophil chemotactic factor produced by lipopolysaccharide stimulated human blood mononuclear leukocytes. I. Partial characterization and separation from interleukin 1. J. Immunol. 139: 788–793.PubMedGoogle Scholar
  9. 9.
    Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocytederived neutrophil chemotactic factor (MDNCF), interleukin 8. J. Immunol. 143: 1366–1371.PubMedGoogle Scholar
  10. 10.
    Standiford, T. J., R. M. Strieter, S. W. Chensue, J. Westwick, K. Kasahara, and S. L. Kunkel. 1990. IL 4 inhibits the expression of IL-8 from stimulated human monocytes. In J. Westwick et al. (Eds). Chemotactic cytokines: biology of the inflammatory peptide supergene family, (in press).Google Scholar
  11. 11.
    Larsen, C. G., M. Kristensen, K. Paludan, B. Deleuran, M. K. Thompsen, K. Kragballe, and K. Matsushima. 1990. Endogenous and synthetic inhibitors of the production of chemotactic cytokines. In J. Westwick et al. (Eds). Chemotactic cytokines: biology of the inflammatory peptide supergene family (in press).Google Scholar
  12. 12.
    Walz, A. and M. Baggiolini. 1990. Generation of the neutrophil activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J. Exp. Med. 171: 449–454.PubMedCrossRefGoogle Scholar
  13. 13.
    Schroeder, J-. M., N. L. M. Pearson, and E. Christophers. 1990. Lipopolysaccharide-stimulated human monocytes secrete apart from NAP-1/IL-8, a second neutrophil-activating protein. J. Exp. Med. 171: 1091–1100.CrossRefGoogle Scholar
  14. 14.
    Wolpe, S. D., G. Davatelis, B. Sherry, B. Beutler, D. Hesse, H. T. Nguyen, L. L. Moldawer, C. F. Nathan, S. F. Lowry and A. Cerami. 1988. Macrophages secrete a novel heparin-binding protein with inflmmatory and neutrophil chemotactic properties. J. Exp. Med. 167: 570–581.PubMedCrossRefGoogle Scholar
  15. 15.
    Wang, J. M., G. Taraboletti, K. Matsushima, J. Van Damme, and A. Mantovani. Induction of haptotactic migration of melanoma cells by NAP 1/IL-8. In J. Westwick et al. (Eds). Chemotactic cytokines: biology of the inflammatory peptide supergene family, (in press).Google Scholar
  16. 16.
    Brown, K. A., F. Le Roy, G. Noble, K. Bacon, R. Camp, A. Vora, and D. C. Dumonde. 1990. IL-8 acts on monocytes to increase their attachment to cultured endothelium and enhance their expression of surface adhesion molecules. In J. Westwick et al. (Eds). 2nd Int. Symp. on Chemotactic Cytokines, (in press).Google Scholar
  17. 17.
    Shiroo, M. and K. Matsushima. 1990. TNF and IL-1 phosphorylate identical cytosolic 65 and 74 kDa proteins in human peripheral blood mononuclear cells. Cytokine 2: 13–20.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Naofumi Mukaida
    • 1
  • Atsushi Hishinuma
    • 1
  • Claus O. C. Zachariae
    • 1
  • Joost J. Oppenheim
    • 1
  • Kouji Matsushima
    • 1
  1. 1.Biological Response Modifiers Program, Cancer Treatment DivisionNational Cancer InstituteFrederickUSA

Personalised recommendations